About: Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

clinical trial

Attributes	Values
rdf:type	Item
description	clinical trial (en) ensayu clínicu (ast) klinisch onderzoek (nl) клінічне випробування (uk)
rdfs:label	Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok (en) Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok (nl)
skos:prefLabel	Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok (en) Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok (nl)
name	Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok (en) Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok (nl)
title	wds:Q65380404-50353F27-78D7-4DB4-AB6F-F5DF1FA9D1BE
title	Evaluation of the Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok® Trivalent Recombinant Baculovirus-Expressed Hemagglutinin Influenza Vaccine In Healthy Adults Aged 18 to 49 (en)
end time	wds:Q65380404-66FAB80A-2149-4757-996C-D9B1506EF949
end time	2008-05-01 00:00:00Z (xsd:dateTime)
instance of	wds:Q65380404-8E4A11A0-FFAD-456A-A6F4-4C4ABB7050FE
instance of	clinical trial
start time	wds:Q65380404-14C06FA4-BA94-421A-B449-CC3B45806B9E
start time	2007-09-01 00:00:00Z (xsd:dateTime)
country	wds:Q65380404-559B8115-C24D-4226-8AD7-955307CA890A
country	United States of America
research site	wds:Q65380404-163730B0-D093-4FF0-BBAC-60A48A1C3793 wds:Q65380404-2B43FCC6-E832-4CDF-8ECD-BC322CCDE5D6 wds:Q65380404-61B0633F-8406-4BCF-960F-BB091C06FBCD wds:Q65380404-64A7AB78-6BFC-453F-8CA1-B7E33AE35DC5 wds:Q65380404-ACEF2FEF-95D2-4382-812D-4BCCDD9A294F wds:Q65380404-C3AADF2B-C1FB-4C61-B408-FCD126ED0C42 wds:Q65380404-FD24288F-00FD-4C4D-B3A0-7CD6754F6323
research site	Saint Louis University Vanderbilt University Medical Center University of Virginia Baylor College of Medicine Meridien Research Jean Brown Research Benchmark Research (United States)
research intervention	wds:Q65380404-08B28208-0487-49A7-8460-CEB289D47FA6
research intervention	hemagglutinin
minimum age	wds:Q65380404-1B7A80B3-981F-4A57-B6A7-51393C9FAF6A
minimum age	18 (xsd:decimal)
number of participants	wds:Q65380404-57F2339E-E315-4274-857E-EA72EF23FF3D
number of participants	4648 (xsd:decimal)
maximum age	wds:Q65380404-2CF5211D-68FB-4BD2-BB41-8046A73B6BC0
maximum age	49 (xsd:decimal)
study type	wds:Q65380404-E551B4CE-C150-42C9-9DE5-D45284117552
study type	interventional study
ClinicalTrials.gov ID	wds:Q65380404-1BA016E4-6946-49B5-99D1-490B6B2016E7
ClinicalTrials.gov ID	NCT00539981
clinical trial phase	wds:Q65380404-9EC608D6-7B3A-4F47-A9A8-40C2E6638BFD
clinical trial phase	phase III clinical trial
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q65380404

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software